EP1009862A1 - Schnelle detection ubd identifizierung von mikroorganismen - Google Patents
Schnelle detection ubd identifizierung von mikroorganismenInfo
- Publication number
- EP1009862A1 EP1009862A1 EP98940684A EP98940684A EP1009862A1 EP 1009862 A1 EP1009862 A1 EP 1009862A1 EP 98940684 A EP98940684 A EP 98940684A EP 98940684 A EP98940684 A EP 98940684A EP 1009862 A1 EP1009862 A1 EP 1009862A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- probe
- micro
- cells
- organism
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 244000005700 microbiome Species 0.000 title claims abstract description 51
- 238000001514 detection method Methods 0.000 title abstract description 43
- 238000000034 method Methods 0.000 claims abstract description 114
- 239000000523 sample Substances 0.000 claims abstract description 102
- 239000000203 mixture Substances 0.000 claims abstract description 69
- 210000002421 cell wall Anatomy 0.000 claims abstract description 23
- 238000010186 staining Methods 0.000 claims abstract description 18
- 241000894006 Bacteria Species 0.000 claims abstract description 15
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 15
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 14
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 14
- 239000000427 antigen Substances 0.000 claims abstract description 8
- 108091007433 antigens Proteins 0.000 claims abstract description 8
- 102000036639 antigens Human genes 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 239000012528 membrane Substances 0.000 claims abstract description 6
- 230000035515 penetration Effects 0.000 claims abstract description 6
- 241000700605 Viruses Species 0.000 claims abstract description 5
- 210000000170 cell membrane Anatomy 0.000 claims abstract description 4
- 239000000834 fixative Substances 0.000 claims abstract description 4
- 241000233866 Fungi Species 0.000 claims abstract description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 3
- 210000004027 cell Anatomy 0.000 claims description 180
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 42
- 102000004190 Enzymes Human genes 0.000 claims description 30
- 108090000790 Enzymes Proteins 0.000 claims description 30
- 229940088598 enzyme Drugs 0.000 claims description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 29
- 108020004999 messenger RNA Proteins 0.000 claims description 26
- 108091034117 Oligonucleotide Proteins 0.000 claims description 20
- 239000002853 nucleic acid probe Substances 0.000 claims description 20
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims description 18
- 238000000684 flow cytometry Methods 0.000 claims description 18
- 230000000593 degrading effect Effects 0.000 claims description 14
- 108091005804 Peptidases Proteins 0.000 claims description 13
- 108020004418 ribosomal RNA Proteins 0.000 claims description 13
- 102000004882 Lipase Human genes 0.000 claims description 11
- 108090001060 Lipase Proteins 0.000 claims description 11
- 239000004367 Lipase Substances 0.000 claims description 11
- 239000007795 chemical reaction product Substances 0.000 claims description 11
- 235000019421 lipase Nutrition 0.000 claims description 11
- 239000004365 Protease Substances 0.000 claims description 9
- 229930006000 Sucrose Natural products 0.000 claims description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 9
- -1 finizym Proteins 0.000 claims description 9
- 229960004793 sucrose Drugs 0.000 claims description 9
- 102000016943 Muramidase Human genes 0.000 claims description 8
- 108010014251 Muramidase Proteins 0.000 claims description 8
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 8
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 8
- 239000004325 lysozyme Substances 0.000 claims description 8
- 229960000274 lysozyme Drugs 0.000 claims description 8
- 235000010335 lysozyme Nutrition 0.000 claims description 8
- 235000019419 proteases Nutrition 0.000 claims description 8
- 125000003396 thiol group Chemical class [H]S* 0.000 claims description 8
- HRNLUBSXIHFDHP-UHFFFAOYSA-N N-(2-aminophenyl)-4-[[[4-(3-pyridinyl)-2-pyrimidinyl]amino]methyl]benzamide Chemical group NC1=CC=CC=C1NC(=O)C(C=C1)=CC=C1CNC1=NC=CC(C=2C=NC=CC=2)=N1 HRNLUBSXIHFDHP-UHFFFAOYSA-N 0.000 claims description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- 102000035195 Peptidases Human genes 0.000 claims description 5
- 238000004163 cytometry Methods 0.000 claims description 5
- 235000019833 protease Nutrition 0.000 claims description 5
- JAJWGJBVLPIOOH-IZYKLYLVSA-M sodium taurocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 JAJWGJBVLPIOOH-IZYKLYLVSA-M 0.000 claims description 5
- 241000196324 Embryophyta Species 0.000 claims description 4
- 150000001720 carbohydrates Chemical class 0.000 claims description 4
- 235000014633 carbohydrates Nutrition 0.000 claims description 4
- 108010009719 mutanolysin Proteins 0.000 claims description 4
- 238000000108 ultra-filtration Methods 0.000 claims description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 3
- 108010067770 Endopeptidase K Proteins 0.000 claims description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004472 Lysine Substances 0.000 claims description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 3
- 229960003237 betaine Drugs 0.000 claims description 3
- 150000001768 cations Chemical class 0.000 claims description 3
- 239000003599 detergent Substances 0.000 claims description 3
- 235000013681 dietary sucrose Nutrition 0.000 claims description 3
- 229960003646 lysine Drugs 0.000 claims description 3
- 238000009007 Diagnostic Kit Methods 0.000 claims description 2
- 108020001027 Ribosomal DNA Proteins 0.000 claims description 2
- 238000002405 diagnostic procedure Methods 0.000 claims description 2
- 238000005558 fluorometry Methods 0.000 claims description 2
- 230000003204 osmotic effect Effects 0.000 claims description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims 1
- 238000003149 assay kit Methods 0.000 claims 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims 1
- 238000011002 quantification Methods 0.000 abstract description 7
- 210000003527 eukaryotic cell Anatomy 0.000 abstract description 4
- 238000011065 in-situ storage Methods 0.000 abstract description 4
- 210000001236 prokaryotic cell Anatomy 0.000 abstract description 3
- 241000195493 Cryptophyta Species 0.000 abstract description 2
- 210000004102 animal cell Anatomy 0.000 abstract description 2
- 239000013612 plasmid Substances 0.000 abstract description 2
- 238000009396 hybridization Methods 0.000 description 67
- 239000000243 solution Substances 0.000 description 67
- 230000008823 permeabilization Effects 0.000 description 31
- 239000000872 buffer Substances 0.000 description 29
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 26
- 230000001580 bacterial effect Effects 0.000 description 24
- 230000000694 effects Effects 0.000 description 24
- 108090000623 proteins and genes Proteins 0.000 description 19
- 238000002474 experimental method Methods 0.000 description 16
- 239000008188 pellet Substances 0.000 description 15
- 244000057717 Streptococcus lactis Species 0.000 description 14
- 230000003321 amplification Effects 0.000 description 14
- 238000003199 nucleic acid amplification method Methods 0.000 description 14
- 239000007858 starting material Substances 0.000 description 14
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 13
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 13
- 238000002372 labelling Methods 0.000 description 13
- 239000002751 oligonucleotide probe Substances 0.000 description 13
- 239000011780 sodium chloride Substances 0.000 description 13
- 235000014897 Streptococcus lactis Nutrition 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 12
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 12
- 238000005259 measurement Methods 0.000 description 12
- 238000007901 in situ hybridization Methods 0.000 description 11
- 238000005406 washing Methods 0.000 description 11
- 239000012901 Milli-Q water Substances 0.000 description 10
- 238000005119 centrifugation Methods 0.000 description 10
- 230000002255 enzymatic effect Effects 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 239000000758 substrate Substances 0.000 description 10
- 108020004465 16S ribosomal RNA Proteins 0.000 description 9
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 9
- 239000006285 cell suspension Substances 0.000 description 9
- 229940040461 lipase Drugs 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 8
- 102000053602 DNA Human genes 0.000 description 8
- NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 description 8
- 108010053775 Nisin Proteins 0.000 description 8
- 235000013351 cheese Nutrition 0.000 description 8
- 238000012258 culturing Methods 0.000 description 8
- 238000011534 incubation Methods 0.000 description 8
- 239000004309 nisin Substances 0.000 description 8
- 235000010297 nisin Nutrition 0.000 description 8
- 241000894007 species Species 0.000 description 8
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 7
- 244000153066 Lactobacillus helveticus DSM 20075 Species 0.000 description 7
- 235000010727 Lactobacillus helveticus DSM 20075 Nutrition 0.000 description 7
- 238000005286 illumination Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 6
- 229930040373 Paraformaldehyde Natural products 0.000 description 6
- 108091093037 Peptide nucleic acid Proteins 0.000 description 6
- 108010013639 Peptidoglycan Proteins 0.000 description 6
- 230000009089 cytolysis Effects 0.000 description 6
- 229920002866 paraformaldehyde Polymers 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- JJAHTWIKCUJRDK-UHFFFAOYSA-N succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate Chemical compound C1CC(CN2C(C=CC2=O)=O)CCC1C(=O)ON1C(=O)CCC1=O JJAHTWIKCUJRDK-UHFFFAOYSA-N 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000001413 cellular effect Effects 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 244000005709 gut microbiome Species 0.000 description 5
- 239000010452 phosphate Substances 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 5
- 229920002477 rna polymer Polymers 0.000 description 5
- WBWWGRHZICKQGZ-HZAMXZRMSA-N taurocholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@@H](O)C1 WBWWGRHZICKQGZ-HZAMXZRMSA-N 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 241000186000 Bifidobacterium Species 0.000 description 4
- 108010059712 Pronase Proteins 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000004132 cross linking Methods 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Inorganic materials [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 239000003068 molecular probe Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- DZGWFCGJZKJUFP-UHFFFAOYSA-N tyramine Chemical compound NCCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-N 0.000 description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 244000199866 Lactobacillus casei Species 0.000 description 3
- 235000013958 Lactobacillus casei Nutrition 0.000 description 3
- 240000002605 Lactobacillus helveticus Species 0.000 description 3
- 235000013967 Lactobacillus helveticus Nutrition 0.000 description 3
- 102000003992 Peroxidases Human genes 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 229910000397 disodium phosphate Inorganic materials 0.000 description 3
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 229940017800 lactobacillus casei Drugs 0.000 description 3
- 229940054346 lactobacillus helveticus Drugs 0.000 description 3
- 125000005647 linker group Chemical group 0.000 description 3
- 210000004962 mammalian cell Anatomy 0.000 description 3
- 229920000515 polycarbonate Polymers 0.000 description 3
- 239000004417 polycarbonate Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 210000003705 ribosome Anatomy 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
- NITXODYAMWZEJY-UHFFFAOYSA-N 3-(pyridin-2-yldisulfanyl)propanehydrazide Chemical compound NNC(=O)CCSSC1=CC=CC=N1 NITXODYAMWZEJY-UHFFFAOYSA-N 0.000 description 2
- OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 description 2
- 239000004971 Cross linker Substances 0.000 description 2
- 239000003298 DNA probe Substances 0.000 description 2
- QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 2
- 241000194036 Lactococcus Species 0.000 description 2
- 208000026681 Paratuberculosis Diseases 0.000 description 2
- 101710176384 Peptide 1 Proteins 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N argon Substances [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000006037 cell lysis Effects 0.000 description 2
- 230000008618 cell wall macromolecule catabolic process Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000011496 digital image analysis Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000001317 epifluorescence microscopy Methods 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- VUFNRPJNRFOTGK-UHFFFAOYSA-M sodium;1-[4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexanecarbonyl]oxy-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].O=C1C(S(=O)(=O)[O-])CC(=O)N1OC(=O)C1CCC(CN2C(C=CC2=O)=O)CC1 VUFNRPJNRFOTGK-UHFFFAOYSA-M 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 229960003732 tyramine Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- QGKMIGUHVLGJBR-UHFFFAOYSA-M (4z)-1-(3-methylbutyl)-4-[[1-(3-methylbutyl)quinolin-1-ium-4-yl]methylidene]quinoline;iodide Chemical compound [I-].C12=CC=CC=C2N(CCC(C)C)C=CC1=CC1=CC=[N+](CCC(C)C)C2=CC=CC=C12 QGKMIGUHVLGJBR-UHFFFAOYSA-M 0.000 description 1
- VILFTWLXLYIEMV-UHFFFAOYSA-N 1,5-difluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC([N+]([O-])=O)=C(F)C=C1F VILFTWLXLYIEMV-UHFFFAOYSA-N 0.000 description 1
- FPKVOQKZMBDBKP-UHFFFAOYSA-N 1-[4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexanecarbonyl]oxy-2,5-dioxopyrrolidine-3-sulfonic acid Chemical compound O=C1C(S(=O)(=O)O)CC(=O)N1OC(=O)C1CCC(CN2C(C=CC2=O)=O)CC1 FPKVOQKZMBDBKP-UHFFFAOYSA-N 0.000 description 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 1
- RSZMTXPFGDUHSE-UHFFFAOYSA-N 2-nitro-1-benzofuran Chemical compound C1=CC=C2OC([N+](=O)[O-])=CC2=C1 RSZMTXPFGDUHSE-UHFFFAOYSA-N 0.000 description 1
- BZSVVCFHMVMYCR-UHFFFAOYSA-N 2-pyridin-2-ylpyridine;ruthenium Chemical compound [Ru].N1=CC=CC=C1C1=CC=CC=N1.N1=CC=CC=C1C1=CC=CC=N1.N1=CC=CC=C1C1=CC=CC=N1 BZSVVCFHMVMYCR-UHFFFAOYSA-N 0.000 description 1
- JMUAKWNHKQBPGJ-UHFFFAOYSA-N 3-(pyridin-2-yldisulfanyl)-n-[4-[3-(pyridin-2-yldisulfanyl)propanoylamino]butyl]propanamide Chemical compound C=1C=CC=NC=1SSCCC(=O)NCCCCNC(=O)CCSSC1=CC=CC=N1 JMUAKWNHKQBPGJ-UHFFFAOYSA-N 0.000 description 1
- VIIIJFZJKFXOGG-UHFFFAOYSA-N 3-methylchromen-2-one Chemical compound C1=CC=C2OC(=O)C(C)=CC2=C1 VIIIJFZJKFXOGG-UHFFFAOYSA-N 0.000 description 1
- HUDPLKWXRLNSPC-UHFFFAOYSA-N 4-aminophthalhydrazide Chemical compound O=C1NNC(=O)C=2C1=CC(N)=CC=2 HUDPLKWXRLNSPC-UHFFFAOYSA-N 0.000 description 1
- MDOJTZQKHMAPBK-UHFFFAOYSA-N 4-iodo-3-nitrobenzamide Chemical compound NC(=O)C1=CC=C(I)C([N+]([O-])=O)=C1 MDOJTZQKHMAPBK-UHFFFAOYSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- 108010000239 Aequorin Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000044503 Antimicrobial Peptides Human genes 0.000 description 1
- 108700042778 Antimicrobial Peptides Proteins 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 241000193163 Clostridioides difficile Species 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 108020005199 Dehydrogenases Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000208011 Digitalis Species 0.000 description 1
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
- 229910052693 Europium Inorganic materials 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 241000204888 Geobacter sp. Species 0.000 description 1
- 102000005548 Hexokinase Human genes 0.000 description 1
- 108700040460 Hexokinases Proteins 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000194034 Lactococcus lactis subsp. cremoris Species 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 102000003939 Membrane transport proteins Human genes 0.000 description 1
- 108090000301 Membrane transport proteins Proteins 0.000 description 1
- 241000186367 Mycobacterium avium Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- OVRNDRQMDRJTHS-RTRLPJTCSA-N N-acetyl-D-glucosamine Chemical class CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-RTRLPJTCSA-N 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 102000019280 Pancreatic lipases Human genes 0.000 description 1
- 108050006759 Pancreatic lipases Proteins 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 235000014962 Streptococcus cremoris Nutrition 0.000 description 1
- 229910052771 Terbium Inorganic materials 0.000 description 1
- 241000589886 Treponema Species 0.000 description 1
- 239000004110 Zinc silicate Substances 0.000 description 1
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical class C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 238000011138 biotechnological process Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 235000012206 bottled water Nutrition 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 238000003200 chromosome mapping Methods 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 239000006059 cover glass Substances 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- LSXWFXONGKSEMY-UHFFFAOYSA-N di-tert-butyl peroxide Chemical compound CC(C)(C)OOC(C)(C)C LSXWFXONGKSEMY-UHFFFAOYSA-N 0.000 description 1
- 239000012969 di-tertiary-butyl peroxide Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
- ZLFRJHOBQVVTOJ-UHFFFAOYSA-N dimethyl hexanediimidate Chemical compound COC(=N)CCCCC(=N)OC ZLFRJHOBQVVTOJ-UHFFFAOYSA-N 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
- GWQVMPWSEVRGPY-UHFFFAOYSA-N europium cryptate Chemical compound [Eu+3].N=1C2=CC=CC=1CN(CC=1N=C(C=CC=1)C=1N=C(C3)C=CC=1)CC(N=1)=CC(C(=O)NCCN)=CC=1C(N=1)=CC(C(=O)NCCN)=CC=1CN3CC1=CC=CC2=N1 GWQVMPWSEVRGPY-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000019249 food preservative Nutrition 0.000 description 1
- 239000005452 food preservative Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000001632 homeopathic effect Effects 0.000 description 1
- 210000003917 human chromosome Anatomy 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 238000003365 immunocytochemistry Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- VWKNUUOGGLNRNZ-UHFFFAOYSA-N methylbimane Chemical compound CC1=C(C)C(=O)N2N1C(C)=C(C)C2=O VWKNUUOGGLNRNZ-UHFFFAOYSA-N 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000007479 molecular analysis Methods 0.000 description 1
- 238000009343 monoculture Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- RQUGVTLRYOAFLV-UHFFFAOYSA-N n-(4-aminobutyl)-4-azido-2-hydroxybenzamide Chemical compound NCCCCNC(=O)C1=CC=C(N=[N+]=[N-])C=C1O RQUGVTLRYOAFLV-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 229940116369 pancreatic lipase Drugs 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- AJMSJNPWXJCWOK-UHFFFAOYSA-N pyren-1-yl butanoate Chemical compound C1=C2C(OC(=O)CCC)=CC=C(C=C3)C2=C2C3=CC=CC2=C1 AJMSJNPWXJCWOK-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- ULARYIUTHAWJMU-UHFFFAOYSA-M sodium;1-[4-(2,5-dioxopyrrol-1-yl)butanoyloxy]-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].O=C1C(S(=O)(=O)[O-])CC(=O)N1OC(=O)CCCN1C(=O)C=CC1=O ULARYIUTHAWJMU-UHFFFAOYSA-M 0.000 description 1
- 244000000000 soil microbiome Species 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003537 structural cell Anatomy 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 239000002352 surface water Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- XSMMCTCMFDWXIX-UHFFFAOYSA-N zinc silicate Chemical compound [Zn+2].[O-][Si]([O-])=O XSMMCTCMFDWXIX-UHFFFAOYSA-N 0.000 description 1
- 235000019352 zinc silicate Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6841—In situ hybridisation
Definitions
- the invention relates to the field microbiology, more specifically to the field of detection, identification and quantification or enumeration of micro-organisms.
- Microorganisms such as viruses, plasmids, bacteria, yeasts, fungi, algae, protozoa, plant or animal cells, and other prokaryotic or eukaryotic cells are in general unicellular organisms with dimensions beneath the limits of vision which thus escape easy detection.
- Micro-organisms are omni -present , complex (mixed) populations can be present in materials as divers as (sea) water, bodily tissues or fluids, pharmaceutical preparations, foodstuffs, industrial products, waste, soil, plants, animals, other micro-organisms, and often their (specific) presence needs to be detected or monitored.
- Micro-organisms for example are widely used in fermentation processes, can be involved as pathogen in disease, and may be used in modern (recombinant) biotechnology; here, as elsewhere, it is essential to be able to properly identify and quantify the micro-organism (s) involved.
- culturing techniques are used to establish the microbial status of a material.
- Culturing micro-organisms is an established way of isolating, detecting, identifying or quantifying them.
- a great number of micro-organisms can in general be cultured, propagated and manipulated in the laboratory, there are also micro-organisms for which culturing methods have not been developed or for which laboratory culture may be difficult if not impossible.
- virus, and other intra-cellular organisms in general, cell-cultures are needed in which said organism grows to detect, identify or quantify the specific organism.
- Other micro-organisms can be isolated and grown in various culture media under various, often very specific, conditions.
- Quantifying the number of specific organisms present in starting material via culture techniques is relatively easy when it concerns starting material containing only one specific organism, e.g. in the case of monocultures. Such quantification can then be done using e.g. limited dilution tests.
- starting material that contains mixed populations of micro-organisms the identity and/or the relative presence or absolute numbers of various organisms need to be known, culturing gets often very cumbersome and tedious, and may even be impractical or impossible for several of the organisms present in the starting material, leading to biased results.
- Probes such as specific antibodies, labelled directly or indirectly with reporter molecules (chromophores or enzymes and corresponding substrates) and used in e.g. immuno-cytochemistry, generally react with antigens (especially (poly) peptides or (glyco) proteins) that are specific for a certain microorganism.
- nucleic acid probes or primers reactive with specific nucleic acids find application in in si tu hybridisation techniques, such as FISH (fluorescent in si tu hybridisation) or in in si tu amplification techniques such as in si tu PCR (polymerase chain reaction) .
- Detection of the labelled antibodies or probes or amplified sequences occurs generally by microscopic observation of the material tested.
- Cells are first immobilised on slides (fixed and lysed e.g. by drying, ethanol fixation, etc.) and subsequently reacted with antibody or nucleic acid (labelled) probes.
- cells can be kept in suspension until after the probe reaction, after which the suspension is filtered and the cells remain immobilised on a filter disc for analysis. Subsequent amplification of the probe signal allows detection of the labelled cells by microscope.
- Semi-automated systems, using digital image analysis and image intensification (image cytometric analysis) have been designed to help study microscopic preparations.
- image cytometry has the disadvantage that, in practical terms, at most some 500 to 1000 individual cells per microscopic preparation can be analysed.
- a major drawback of above microscopic techniques is the limited sample throughput. The long analysis time required limits the maximum throughput to 20 to 50 samples per day.
- fixation and lysis of the cells in general suffices to immobilise antigens and nucleic acid to the cytoskeleton or the various organelles present in the cell, the cell in itself disintegrates and gets fragmented due to the fixation and lysis.
- those antigens and nucleic acids that are for example present (in solution) in the cytosol will disappear during fixation and lysis and cannot be detected.
- no insight can be gained by above microscopic techniques about (current) enzymatic and/or mRNA activity of the micro-organisms studied.
- this basic problem in in si tu staining using signal amplification systems relates to the diffusion of large-molecular weight molecules, such as enzymes, antibodies or (strept) avidin, into whole fixed cells.
- the permeabilization gets more difficult for larger molecules since -the margin between the community of target molecules and the loss of target molecules or complete cell lysis becomes very narrow (Amman et al . , Microbiol . Rev. 59:143-169, 1995; Schonhuber et al , Appl . and Env. Microbiol. 63:3268-3273, 1997).
- Permeabilization of cells walls by pretreatment with lysozyme (EDTA) in general allow a restricted set of bacteria to be investigated, whereby it must be noted that lysozyme degradation often only permeabilises a minor fraction of the tested cells (causing heterogenous signals) and is in general only applicable with cells fixed on microscopic slides but not with cells in suspension.
- lysozyme degradation often only permeabilises a minor fraction of the tested cells (causing heterogenous signals) and is in general only applicable with cells fixed on microscopic slides but not with cells in suspension.
- Rapid techniques to monitor the development of individual species or strains, and/or their (current) enzymatic activity, involved in fermentation processes comprising complex mixtures of species would relay important information related to the management and control of such processes .
- Rapid flow cytometric techniques such as FACSCAN
- FACSCAN Fluorescence Activated Cell Sorting
- PNA peptide nucleic acid
- Nucleic acid probes used in the method of the invention are provided as well.
- most nucleic acid molecules in the cell are relatively little or not denatured, thereby greatly hampering hybridisation of most probes that otherwise would hybridise easily with stretches of denatured nucleic acid molecules .
- An example of such probes provided by the invention is given in Table 3.
- a further embodiment of the invention entails a method wherein said probe is labelled with a reporter molecule, for example a reporter molecule selected from any of the group of fluorochromes and enzymes .
- a preferred embodiment of the invention is a method wherein the reporter molecule is horseradish-peroxidase, preferably linked with a sulfo-SMCC linker to said probe.
- a further embodiment of a method provided by the invention is a method wherein the presence of said (bound) probe is detected by microscopy, image cytometry, fluorometry or flow cytometry, preferably be detecting fluorescence.
- a preferred embodiment of the invention is a method wherein the fluorescence of tyramine- fluorchromes is detected.
- a preferred embodiment of the invention is the use of a method of in si tu staining provided by the invention wherein the micro-organism is not immobilized, for example to a slide or filter, but wherein detection of the stained micro-organism occurs in suspension.
- a composition comprising a cell -wall degrading reagens for use in in si tu staining.
- a cell wall degrading reagens comprises at least one detergent, such as sodium taurocholate and at least one enzyme, such as a lipase and/or aditionally comprises a carbohydrate degrading enzyme such as lysozyme, finizym, or mutanolysin.
- said composition comprises at least one os oticum, such as saccharose, sucrose, or lysine betaine, to regulate osmotic pressure and/or at least one cation, such as Ca ++ or Li + (but nor Mg ++ ) .
- Said composition may be optionally buffered, for example with Tris-HCl.
- a nucleic acid probe linked with horseradish-peroxidase Said probe and horseradish-peroxidase are preferably linked with a sulfo-SMCC linker.
- a diagnostic test kit for use with in si tu staining.
- Such a kit provided by the invention at least comprises a cell wall -degrading composition and/or nucleic acid probe provided by the invention, and can additionally at least comprise fixative, substrate, or buffer provided by the invention.
- the HRP-nucleic acid probe provided by the invention is also provided for use in other tests systems than in si tu assays alone.
- Such a probe can for example be used in enzym-linked assays , such as a dip-stick but other formats are also possible, for the rapid detection of genes or gene-products in for example lysed bacterial samples.
- the deposited reporter molecules can additionally serve as hapten for, e.g., anti-fluorescein-AP, antibo ' dies via which an extra amplification step and the detection of very low numbers of target molecules is possible.
- image cytometric analysis is in general terms an appropriate tool for the extraction of morphological features or localisation parameters (e.g., as in genome-mapping of eukaryotic cells) , signal amplification is ultimately desirable when natural mixed populations of bacteria (such as those occurring in seawater) are to be investigated.
- Image cytometry has the disadvantage that in practical terms, at the most, some 500 to 1,000 individual cells per microscopic preparation can be analysed. Furthermore, the long analysis time required limits the maximum throughput to about 50 samples per day.
- the relatively small number of samples that can be tested render the automation of the fluorescence in si tu hybridization technique practically and economically unattainable.
- Flow cytometric analysis of samples would enable large scale analysis, if technically feasible.
- the present invention enables rapid flow cytometric acquisition of quantitative data from probe-labelled cells and the possibility to automate methods for in si tu identification based on nucleic acid probes through generation of unequivocally high signals from such labels.
- the level of cellular (enzymatic) activity of cells is of considerable interest.
- the possibility to attach to individual cells not only a name but also an activity in a routine procedure cq. a practical protocol, will greatly advance microbiology.
- the present invention allows for controlled degradation of for example bacterial cell walls in combination with an amplification technique for the measurement of rRNA in micro- organisms thus allowing in si tu staining and detection, for example by flow cytometric detection.
- the present invention provides a signal amplification of at least 30-50 fold, and even 8O fold, as compared with conventional fluorescent probes.
- the invention also provides a method to determine the amount of messenger RNA in micro-organisms and mammalian cells.
- the commercial impact of the any molecular analysis method stands or falls with possibilities to enlarge the scale and reduce the cost. For large scale analysis, the ability to automate methodologies is crucial. In the ideal case, a sample is taken, directly inserted into an instrument and the data are printed.
- ISH si tu hybridisation
- FISH Fluorescence in situ hybridisation
- RNA's the multi-copy transcripts of the DNA, are naturally amplified within each living cell, as such, they represent ideal targets for genetic labelling techniques.
- each bacterial cell contains some 20.000 identical ribosomal RNA (rRNA) molecules and some 200 identical messenger RNA (mRNA) molecules. If each of these molecules was tagged by one fluorochrome, signals would not be sufficient to automate the analysis.
- mRNA molecules represent the "coding" intermediates between DNA and proteins for which the genetic code is contained in the genome.
- mRNA-ISH messenger RNA in si tu hybridization
- the invention provides specific protocols, means and methods that are needed to permeabilize the (bacterial) cell wall. Furthermore, the invention provides a method to couple the HRP molecule directly to the nucleic acid probe via a C 6 -thiol linker. Such a nucleic acid probe is derived from a thiolated probe linked to horseradish-peroxidase with a sulfo-SMCC linker, or a linker equivalent thereto.
- the invention herewith provides a method for linking a nucleic acid probe to horseradish peroxidase comprising mixing a thiol oligonucleotide with a SMCC-HRP complex, incubating said mixture and purifying it by ultrafiltration.
- a labelled probe provided by the invention, the invention provides a probe molecule which is small enough to penetrate a cell wall when this barrier is properly and controllably degraded.
- various cell wall degrading reagents and compositions are provided by the invention that allow the penetration of a HRP enzyme linked to an oligonucleotide by a C6-thiol linker into bacterial cells.
- tyramide-fluorochro es are constructed that act as substrate for the HRP.
- the resulting tyramide-fluorochrome radicals attach randomly in the cell whereby fluorescence is attained for very long periods (up to months) .
- the methods and means provided by the invention allow for example the direct detection of specific bacterial species (through rRNA-probing) in environmental, clinical or industrial samples via microscopic observation, automated image analysis or flow cytometric methods. Also, potential enzymatic activity determined by the quantification of mRNA species can be measured in si tu in whole cells. Also, the method and means provided by the invention allow the detection of single genes within individual bacterial cells by using microscopic (image) analysis or flow cytometry.
- the invention allows for the use of any fluorochrome (fluorescein, rhodamine, coumarine, etc.) that can be amino- esterified. This enables the use of multiple-colors, and thus the detection of various parameters simultaneously.
- measuring mRNA in whole bacterial cells by in si tu hybridisation to detect expression of certain genes is cumbersome, when not using the methods and means provided by the invention.
- the reported method uses large multiple- labelled transcript probes (some 200 nucleotides long) instead of the small synthetic oligonucleotide probes and is not of great commercial interest since the production of the large transcript-probe used is very tedious and cannot be performed on a routine basis.
- ELFTM Molecular Probes, Eugene, USA
- a fluorescent precipitate is formed that will not diffuse away.
- this methodology cannot be used for bacteria since the necessary enzyme (alkaline phosphatase) is more than twice as large as peroxidase and cannot enter the bacterial cell wall without significant damage to cellular integrity and morphology.
- the method linking HRP to nucleic acid probes as is provided by the invention can be used to label for example peptide nucleic acid (PNA) -probes as well as oligonucleotide-probes .
- PNA peptide nucleic acid
- the methods and means provided by the invention can be used to screen large amounts of samples for the presence of cells that harbour bacteriophage or virus .
- the HRP-nucleic acid probe provided by the invention can also be used in other tests systems than in si tu assays alone.
- Such a probe can for example be used in enzym-linked assays , such as a dip-stick but other formats are also possible, for the rapid detection of genes or gene-products in lysed bacterial samples.
- the deposited reporter molecules can additionally serve as hapten for, e.g., anti- fluorescein-AP, antibodies via which an extra amplification step and the detection of very low numbers of target molecules is possible.
- the methods and means provided by the invention find application for example as diagnostic kit in the broad field of microbiology.
- a (non-extensive) list may include several possibilities, such as: To study the effect of novel foods (prebiotics) , probiotics, and functional foods on the intestinal microflora of both man and animal . To monitor the development of mixed bacterial populations that are essential for industrial fermentation processes in classical (cheese and other dairy fermentation, beer, wine, etc.) as well as in modern biotechnology (heterologous (over) expression of proteins, etc.). To rapidly detect microbial contamination in product or production tools from raw material to end product (hygiene control) . To identify and quantify the presence and activity of micro-organisms in wastewater treatment systems.
- the permeabilization procedure allows for the first time the performance of in si tu hybridization experiments with all of the bacteria which contain rigid polysaccharide capsules, extensive peptidoglycan layers, extraordinary cross-linking moieties in their peptidoglycan layer and/or that can prevail in the form of impermeable spores. Cells need not be brought to the vegetative state prior to in si tu hybridization.
- the invention allows for the first time the direct detection of non-growing cells or cells obtained directly from the natural environment by in si tu hybridization.
- the present method ensures sufficient signal amplification as to yield fluorescence signals strong enough to allow the in si tu detection by fluorescence in situ hybridization of low copy numbers of rRNA molecules.
- the present invention provides a methodology to detect, e.g., Mycobacterium tuberculosis directly in sputum samples or bacteria obtained from soil or bacteria obtained from watersamples by in situ hybridization.
- Such cells normally contain only 50-100 ribosomes and can not be detected by conventional fluorescence in si tu hybridization.
- the invention allows for the first time the direct detection of messenger RNA's by in si tu hybridization.
- the present method ensures sufficient signal amplification as to yield fluorescence signals strong enough to allow the in si tu detection by fluorescence in situ hybridization of the naturally (very) low copy numbers of mRNA. Therefore, the present invention provides a methodology to detect, e.g., protease gene expression in Lactococcus lactis cells by in si tu hybridization.
- Such cells normally contain only 50-100 mRNA molecules that can not be detected by conventional fluorescence in si tu hybridization.
- the invention allows for the first time the direct detection of streptococci by in si tu hybridization.
- the present method provides for a permeabilization formula which can permeabilize streptococcal cell-walls without the need of prior formaldehyde fixation.
- the present invention thereby provides a methodology to detect, e.g., streptococci by in situ hybridization. Such cells can not be detected by conventional fluorescence in si tu hybridization techniques.
- the invention allows for the first time the quantitative measurement of cells stained by in si tu hybridization on a flow cytometer.
- the present method provides for a methodology with which cell lysis is prevented. Due to such a prevention, post-hybridization washing of cells is now effective (no background signal) and cells can be measured quantitatively by using methods such as flow cytometry.
- the invention provides for the first time an optimized methodology of in si tu hybridization staining by which cells from natural samples, such as occur in feacal flora, can be measured on a flow cytometer.
- the present method provides for a methodology in which the pH of the buffer is adjusted such that FISH-derived fluorescence is optimal . Due to such an optimization, post-hybridization fluorescence is high enough to ensure that cells can be measured quantitatively by using methods such as flow cytometry.
- the invention describes a washing procedure that allows an effective post -hybridization washing of hybridized cells while maintaining sufficient cell density for flow cytometric measurement .
- the present invention provides for a permeabilization formula that allows for the first time the performance of in si tu hybridization experiments with all of the bacteria which either contain rigid polysaccharide capsules, extensive peptidoglycan layers, extraordinary cross-linking moieties in their peptidoglycan layer and/or that can prevail in the form of impermeable spores and that breaks down all structural cell wall components in a controlled fashion.
- One of the embodiments of the present invention is a permeabilization formula
- another embodiment of the present invention is a signal amplification methodology which, when used in combination ensure i) the formation of pores or gaps in the cell wall of sufficient size as to facilitates the entering of bulky molecules such as horseradish peroxidase enzymes conjugated to oligonucleotides and ii) that facilitates the formation through such molecules of sequence-specific fluorescent precipitates thus allowing the microscopic or flow cytometric detection of cells stained by fluorescence in situ hybridization.
- Example 1 Cell wall -degrading composition
- Solution A 20 ml 48% (w.v) sucrose solution (9.6 g sucrose in 20 ml of Milli-Q water) ; sterilize by autoclaving;
- Solution B 1 ml 1% (w/v) sodium taurocholate solution
- Tris (hydroxymethyl) -aminomethane in 90 ml of Milli-Q water add cone. HCl to pH 7.5, add
- Solution E 1 ml 20% (w/v) lysozym solution (200 mg lysozym in 1 ml of sterilized Milli-Q water) ;
- Solution F 1 ml 1% (w/v) lipase (10 mg of lipase in 1 ml of sterilized Milli-Q water) ;
- Solution G finizym, no preparations needed; purchase commercially from Novo Nordisk France;
- Solution H 1 ml 10.000 U/ml mutanolysin (10.000 U mutanolysin in 1 ml of sterilized Milli-Q water) ;
- LD-Bos cheese starter culture by mixing 1 ml of culture with 30 ml of 0.2% EDTA. Incubate for 30 min on a roller-bench. Pellet the cells by centrifugation for 10 min at 10.000 rpm. Wash the cell pellet in 15 ml of PBS (1000 ml of Milli-Q water, 8 g of NaCl , 0.2 g of KC1, 1.81 g Na 2 HP0 4 *2H 2 0 and 0.24 g of KH 2 P0 4 , pH 7.4) . Pellet the cells by centrifugation for 10 min at 10.000 rpm.
- PBS 1000 ml of Milli-Q water, 8 g of NaCl , 0.2 g of KC1, 1.81 g Na 2 HP0 4 *2H 2 0 and 0.24 g of KH 2 P0 4 , pH 7.4
- the thus treated cells of the LD-Bos cheese starter culture can be used for in situ hybridization with rRNA, mRNA or DNA-targeted deoxyribonucleic acid (DNA) oligonucleotide probes, ribonucleic acid (RNA) oligonucleotide probes, peptide nucleic acid (PNA) probes that are for their subsequent detection labelled with reporter molecules such as:
- fluorescent labels e.g., fluorescein, rhodamine, methylcoumarine , tertramethylrhodamine ,
- enzymatic labels e.g., oxidases, peroxidases, phosphatases, luciferases, dehydrogenases, hexokinases or papain
- - proteinaceous labels e.g., streptavidin, antibodies, Fab fragments or aequorin
- chemiluminescent labels e.g., acridinium esters, isoluminol, luminol or ruthenium tris [bipyridyl] )
- hapten e.g., biotin, digoxigenin, ethidium, glucosyl, sulfone, either
- the thus treated cells are permeable to large biomolecules and the procedure can be used to introduce large (bio) molecules of any kind in the bacterial cell.
- the procedure can be shortened by combining separate successive steps, e.g., (para) formaldehyde fixation can be combined with ethanol dehydration in one step.
- the (bio) chemicals in the protocol can be substituted for any (bio) chemical with comparable activity, e.g., ethanol can be replaced by methanol or propanol and the enzymes can be changed for enzymes with comparable biological catalytic activity provided that the environment of the reaction is modified according to routine skills to suit the new (bio) chemistry.
- any (bio) chemical with comparable activity e.g., ethanol can be replaced by methanol or propanol
- the enzymes can be changed for enzymes with comparable biological catalytic activity provided that the environment of the reaction is modified according to routine skills to suit the new (bio) chemistry.
- Step 1 De-protection of commercially derived 5 ' - thiol labelled oligonucleotides :
- Deoxyoligonucleotides (10-30 mers) with a protected thiol (SH) group attached to the 5-prime end via a C-6 spacer arm were commercially derived (Eurogentec, Seraing, Belgium) .
- the thiol -groups were de-protected by incubating the oligonucleotide (2 mg/ml) in DP buffer (50 M (Na) phosphate, pH 7.4; 5 mM EDTA; 100 M NaCl; 50 mM hydroxylamine-HCl) for 30 min at 30°C.
- Step 2 Linking of the horseradish peroxidase enzyme to a sulfo-SMCC linker:
- Solution 1 50 mg/ml of sulfo-SMCC (sulfosuccinimidyl 4- [N-maleimidomethyl ] -cyclohexane-1- carboxylate; Pierce, Rockford, IL, USA) in DMSO (dimethylsulfoxide) .
- Solution 2 10 mg/ml of enzyme (HRP; Sigma Chemical
- PEN buffer pH 8.0 (50 mM (Na) phosphate, pH 8.0; 5 mM EDTA; 100 mM NaCl) .
- a volume of 10 ⁇ l of freshly prepared solution 1 was mixed with 200 ⁇ l of solution 2 and the mixture was incubated at 30°C for 1 h.
- 790 ⁇ l of PEN buffer, pH 6.7 (50 mM (Na) phosphate, pH 6.7; 5 mM EDTA; 100 mM NaCl) was added and the SMCC-HRP complex was purified via ultrafiltration using Centricon 30 (Amicon, Beverly, MA, USA) .
- the complex was washed 3 times with PEN buffer, pH 6.7 in Centricon 30 ultrafilters and the supernatant of the final wash was made up to 200 ⁇ l with PEN buffer, pH 6.7.
- a volume of 67 ⁇ l of the deprotected thiol oligonucleotide (step 1) was mixed with 200 ⁇ l of the purified SMCC-HRP complex (step 2) and the mixture was incubated at 30°C for 1.5 h.
- the cross-linked enzyme/oligonucleotide complex was purified via ultrafiltration using Centricon 30 ultrafilters. The complex was washed 3 times with PEN buffer, pH 6.7 in Centricon 30 ultrafilters and the supernatant of the final wash was made up to 67 ⁇ l with PEN buffer, pH 6.7.
- the enzyme-labelled probes were stored at 4°C. For hybridization, the probe-solution was diluted 10 to 100 times in PEN buffer, pH 6.7.
- the (bio) chemicals in the protocol can be substituted for any (bio) chemical with comparable activity, e.g., the cross-linker sulfo-SMCC can be replaced by any cross- linker (such as sulfo-GMBS or DTBP) provided that the environment of the reaction is appropriately modified to suit the new chemistry.
- the cross-linker sulfo-SMCC can be replaced by any cross- linker (such as sulfo-GMBS or DTBP) provided that the environment of the reaction is appropriately modified to suit the new chemistry.
- linkers are succinimidyl- , salicylamido- or hydrazide- derivatives that contain at least two reactive sites that are homobifunctional or heterobifunctional reactive towards (-NH2) amines [e.g., 1, 5-Difluoro-2,4-dinitrobenzene (DFDNB) , Dimethyl adipimidate 2HC1 (DMA) ; or Succinimidyl 4- [N-maleimidomethyl] cyclohexane-1-carboxylate (SMCC) ] (-SH) sulfhydryls
- ASBA 4- [p-Azidosalicylamido] butylamine
- EDC l-Ethyl-3- [3-dimethylaminopropyl] -carbodiimide Hydrochloride
- reaction product A enzyme-labeled oligonucleotides
- reaction product B un-reacted enzyme
- reaction product C enzyme with a SMCC moiety attached to it
- the present invention therefore represents an important improvement of the art.
- the proposed method for preparing the HRP-labeled oligonucleotides is therefore one of the embodiments of the present invention.
- Example 3 HRP-Labelling and use of Fluoresceine-Tyramide in whole cell fluorescence in situ hybridization with Lactococcus lactis cells.
- Fluoresceine-Tyramide (FT) substrate Tyramine (Sigma) was linked to Fluoresceine-NHS (Boehringer) by mixing 15 mg of fluoresceine-NHS in 200 ⁇ l DMSO with 150 ⁇ l tyramine (20 mg/ml H 2 0) and using a 4 h incubation at
- Cells of Lactococcus lactis subsp. cremoris were grown in overnight culture. Cells from two ml of culture were washed in PBS and resuspended in cell wall degrading reagens (50 mM Tris-HCl, pH 7.0; 0.03% (w/v) Na-taurocholate ; 5 mM CaCl 2 , 20% (w/v) sucrose; 0.5% (w/v) lysozym; 0.003% (w/v) pancreatic lipase; 1% v/v finizym.
- cell wall degrading reagens 50 mM Tris-HCl, pH 7.0; 0.03% (w/v) Na-taurocholate ; 5 mM CaCl 2 , 20% (w/v) sucrose; 0.5% (w/v) lysozym; 0.003% (w/v) pancreatic lipase; 1% v/v finizym.
- Hybri di sat ion Hybridisation was carried out by mixing 10 ⁇ l of the cell suspension in ethanol with 90 ⁇ l of hybridisation solution
- washing solution 100 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.05% v/v Tween 20
- cells were either used immediately for flow cytometric analysis or were filtered onto a 0.2 mm pore-size IsoporeTM polycarbonate membrane filter (Millipore Corporation, U.S.A.) for epifluorescence microcopic observation. Filters were mounted on microscope slides with VectashieldTM. Hybridised cells were viewed under blue light excitation using an Olympus BX40 fluorescence microscope using epi-illumination.
- a probe complementary to a universally conserved 16S rRNA bacterial sequence (Eub338) labelled with HRP served as a positive control, whereas a probe labelled with HRP and complementary to the sequence of probe Eub 338 (i.e. probe NonEub338) served as a negative control.
- Hybridization occurred at 37° C for 16 h. After hybridization, slides were washed in hybridization buffer for 20 min at 37°C and mounted in Vectashield (Vector Labs, Ca, USA)
- Example 5 Measurement of activity of single cells via total mRNA quantification by using a poly-T oligonucleotide probe. The activity of individual cells was measured by whole cell in situ hybridization of Escherichia coli strain JM101 .
- Hybri disati on Hybridisation was carried out by mixing 10 ⁇ l of the ethanolic fixed cell suspensions with 90 ⁇ l of hybridisation solution (20 mM Tris-HCl, pH 7.2; 0.9 M NaCl; 0.1% SDS; 0.25 ng/ml FITC-labelled oligonucleotide probe) . Cells were hybridized for 16 h at 45 °C with a FITC-labelled poly-T oligonucleotide probe (20-mer, 5 ' -FITC) , which was commercially derived.
- hybridisation buffer hybridisation solution without probe
- mixture A see permeabilization formula of example 1
- mixture B 60 ⁇ l pronase 100 U/ml , 40 ⁇ l proteinase K 20 mg/ml
- a volume of 30 microlitres of the permeabilized cell suspension is mixed with 1 ml of PBS (see example 1) and cells are pelleted by centrifugation at 14.000 rpm. The pellet is resuspended in 400 ⁇ l of PBS/Ethanol (1:1) and dehydrated at -20°C for 1 hr.
- Cells are pelleted by centrifugation at 14.000 rpm, the pellet is resuspended in 200 ⁇ l of hybridisation mixture (see example 5) and cells are hybridized overnight. A volume of 5 microlitres of the cell suspension is filtered over a 0.2 ⁇ m polycarbonate filter, washed with hybridization buffer and viewed under the microscope using the appropriate filtersets. Fluorescence of cells is scored visually.
- Example 7 Conventional FISH versus FISH with HRP-labeled oligonucleotide probes in the flow cytometric measurements of cells stained by 16S rRNA-FISH.
- Faecal, bacterial samples are prepared by suspending 0.5 grams of fresh faecal material in 4.5 ml of PBS by using a dozen sterile glass beads (3 mm diameter) and a vortex. The suspension is centrifuged at low speed (1,000 rpm) for 1 min and the supernatant - which contains the cells - is transferred to a clean microcentrifuge tube. The cell suspension is then fixed in 4% p-formaldehyde at 4°C for 4 hrs. Cells are washed twice in PBS and resuspended in a mixture of PBS/Ethanol or another organic solvent (1:1) for dehydration and/or partial degradation. Cells are dehydrated for at least 1 hr at -20°C.
- Dehydrated cells are suspended one in ten in hybridization buffer and hybridized as described above without permeabilization. Hybridization was performed with probes NonEub, Eub, Bif and Uni labeled with FITC and NonEub, Eub and Bif labeled with Cy5. Probe concentrations of 2 ng/ ⁇ l were used. Washing was performed both in hybridization buffer from which SDS was ommitted and in ice-cold PBS. In the case of PBS washings, a volume of 1 ml was added to 500 ⁇ l of hybridized cells. The cell suspension was incubated on ice for 5 min and centrifuged at 14,000 rpm for 5 min.
- the resulting cell pellet was resuspended in 35 ⁇ l of ice-cold PBS and stored on ice. Just prior to flow cytomerty, 5 ⁇ l of cell suspension was diluted into 500 ⁇ l of ice-cold PBS and cellular fluorescence was acquired by flow cytometry. In the case of hybridization buffer washings, a volume of 1 ml of pre-warmed (45°C) hybridization buffer without SDS was added to the hybridized cells and incubated for 30 min at 45°C. Cells were pelleted by centrifugation at 14,000 rpm for 5 min and resuspended in 1 ml of pre-warmed (45 °C) hybridization buffer. The results of the FISH procedure are displayed in table 5 and in figs. 4 and 5.
- the cell pellet was resuspended in 100 ⁇ l of hybridization mixture consisting of 10 ⁇ l of non-purified HRP-labeled oligonucleotide (1 in 10 diluted in PEN buffer, see example 2) , 8 ⁇ l of 6M ureum and 82 ⁇ l of hybridization buffer as used above, and incubated for 16 hrs at 37°C. After hybridization, cells were washed for 5 min in 1 ml of hybridization buffer with 0.48 M ureum and pelleted.
- Figs. 6 demonstrates the shift in fluorescence upon labeling with HRP probes in FISH in graphical display.
- the intensity of HRP labeling is comparable to the staining with the nucleic acid stain YOPRO-1 at a dilution of 40x (see fig 5, panel B) .
- These types of intensities are required for flow cytometric detection of FISH in bacterial cells, especially in cells that exist in a low level metabolic state, i.e. in which conventional FISH results in fluorescence levels too low for convenient detection such as soil bacteria or bacteria in natural water bodies.
- Example 8 Detection of nisin mRNA gene-transcripts in Lactococcus lactis.
- Example 4 the procedure used in example 4 is used to detect messenger RNA's in whole cells of Lactococcus lactis for the antimicrobial peptide nisin.
- cells of strain 161-5 of nisin producing Lactococcus lactis were subjected to nisin-inducing growth conditions. Samples were withdrawn every hour for 8 hrs and the cells were treated and hybridized with a HRP-labeled oligonucleotide specific for nisin-mRNA as described in example 4.
- a non-producing strain (strain 1614) served as a negative control in this experiment. Fluorescence was monitored visually and photographs were taken for later verification.
- Example 9 Detection of Lactobacillus helveticus by 16S rRNA-targeted fluorescence in si tu hybridization.
- the cells are dehydrated in a graded ethanol series (50%, 70% and 100% of ethanol) by submersing the entire slides in the various ethanol solutions for 2 min.
- the slides are dried to air and a volume of 50 ⁇ l of hybridization mixture with FITC labeled probes is applied to the slides.
- the entire slide is covered by a large cover glass, and incubated in a hybridization chamber for a period of 4 hrs.
- Upon hybridization, slides are washed in hybridization buffer at 45 °C for 5 min, dried in air and mounted for microscopic examination.
- NAM N-acetylmuramic sugar / structura acids
- the pH of the measuring buffer was 7.4 in these experiments.
- FIG. 1 Illumination series demonstrating the enormous (80x) increase in fluorescence emission from HRP-labelled probe (photograph D: 0.5 sec illumination) compared to conventional FITC-labelled oligonucleotide probes (photographs A, B and C: 0.5, 4 and 10 sec illumination, respectively) .
- Hybridizations were performed on cheese starter-culture LD-Bos.
- the HRP-labelled probe used was targeted to the 23S rRNA of Lactococcus lactis subspecies cremoris cells (over 50%) .
- the FITC-labelled probe was targeted to the 16S rRNA of all bacterial cells present in the sample.
- the protocol for in situ hybridization with HRP- labelled probes of example 1 was applied.
- the average fluorescence of cells in photograph D was 181, that of photograph C was 53 (in AU) as determined by image cytometry.
- Figure 3 Measurement of mRNA via an FITC-labelled poly-T oligonucleotide probe in individual Escherichia coli cells by flow cytometry.
- Figure 4 Flow cytometer cytograms representing the measurements of human intestinal (faecal) flora with Bifidobacterium genus- specific 16S rRNA targeted in si tu hybridization probes labeled at the 5 ' end with FITC (panel A) and Cy5 (panel B) . Fluorescence intensities (y-axis) are plotted versus Forward Scattering Signal (x-axis) . With both labels, a distinct group of cells with higher fluorescence than the body of the population can be distinguished. Pthe pH of the measuring medium was 10.4 for FITC and 7.5 for Cy5 with TOPRO-3 and YOPRO-1 as the DNA counter stains for FITC and Cy5, respectively.
- Panel B top: The YOPRO-1 fluorescence (x-axis) versus the cell counts-. YOPRO-1 was applied as a 4Ox diluted commercial preparation. Panel B, bottom; The Cy5 fluorescence derived from these cells (x-axis) versus the cell counts. Panel C, top: The Cyto- 9 fluorescence (x-axis) versus the cell counts. Panel C, bottom; The Cy5 fluorescence derived from these cells (x-axis) versus the cell counts.
- Panel B 5' end with HRP (panel B) .
- No nucleic acid-counterstains were used.
- Panel B, top The FITC fluorescence derived from HRP-labeled probe LLC used in combination with FT-substrate (x-axis) versus the cell counts.
- Nisin mRNA detection in Lactococcus lactis Panel A: Non nisin-producing strain 1614 after 3 hrs of growth under nisin-inducing conditions. Panel B: Nisin-producing strain 161-5 at various times during 6 hrs of growth under nisin- inducing conditions. See text for details.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98940684A EP1009862A1 (de) | 1997-08-26 | 1998-08-26 | Schnelle detection ubd identifizierung von mikroorganismen |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97202618 | 1997-08-26 | ||
| EP97202618 | 1997-08-26 | ||
| EP98940684A EP1009862A1 (de) | 1997-08-26 | 1998-08-26 | Schnelle detection ubd identifizierung von mikroorganismen |
| PCT/NL1998/000481 WO1999010533A1 (en) | 1997-08-26 | 1998-08-26 | Rapid detection and identification of micro-organisms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1009862A1 true EP1009862A1 (de) | 2000-06-21 |
Family
ID=8228676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP98940684A Withdrawn EP1009862A1 (de) | 1997-08-26 | 1998-08-26 | Schnelle detection ubd identifizierung von mikroorganismen |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1009862A1 (de) |
| AU (1) | AU8890498A (de) |
| WO (1) | WO1999010533A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000065093A2 (en) * | 1999-04-22 | 2000-11-02 | Science And Technology Corporation | In situ hybridization methods for reducing the occurrence of false positives and for targeting multiple microorganisms |
| WO2000065092A2 (en) * | 1999-04-22 | 2000-11-02 | Science And Technology Corporation | Blocking non-specific binding of granulocytes in microorganism detection |
| US7060432B1 (en) * | 1999-06-15 | 2006-06-13 | Applera Corporation | Methods for the detection, identification, and/or enumeration of yeast, particularly in wine |
| DE102007047312A1 (de) * | 2007-10-02 | 2009-04-09 | H.C. Starck Gmbh | Werkzeug |
| CN105158223A (zh) * | 2015-08-24 | 2015-12-16 | 中国科学院海洋研究所 | 一种基于溶菌酶功能的小分子标记荧光信号系统及其应用 |
| DE102020103957B4 (de) * | 2020-02-14 | 2022-01-13 | Testo bioAnalytics GmbH | Verfahren zum Nachweis von Mikroorganismen und ein fluidisches Kanalsystem |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1224253B (it) * | 1988-04-08 | 1990-09-26 | Sclavo Spa | Oligonucleotidi sintetici utili per la determinazione di chlamydia trachomatis in un campione biologico |
| EP0422861B1 (de) * | 1989-10-13 | 2000-05-17 | Zeneca Limited | Sonden |
| WO1992009704A1 (en) * | 1990-11-29 | 1992-06-11 | Diagnostic Hybrids, Inc. | Method for in situ detection and identification of nucleic acid sequences |
| EP0497464A1 (de) * | 1991-01-31 | 1992-08-05 | Amoco Corporation | Schnellnachweis von Mikroben durch in situ-Hybridisation in wässeriger Suspension |
| AU5355594A (en) * | 1992-10-09 | 1994-05-09 | Oncor, Inc. | Methods for the detection of chromosome structural abnormalities by (in situ) hybridization to fixed tissue |
| US5523204A (en) * | 1993-12-10 | 1996-06-04 | Becton Dickinson And Company | Detection of nucleic acids in cells by strand displacement amplification |
| AUPN283195A0 (en) * | 1995-05-05 | 1995-06-01 | Australian Water Technologies Pty Ltd | Method for the detection of viable cryptosporidium parvum cells |
| JP2001502881A (ja) * | 1995-05-18 | 2001-03-06 | アボツト・ラボラトリーズ | 高分子ペプチドプローブ及びその使用 |
| WO1997005282A2 (en) * | 1995-07-28 | 1997-02-13 | Rijksuniversiteit Groningen | Methods and materials for determining relative abundance of microorganisms in mixed populations |
-
1998
- 1998-08-26 EP EP98940684A patent/EP1009862A1/de not_active Withdrawn
- 1998-08-26 WO PCT/NL1998/000481 patent/WO1999010533A1/en not_active Ceased
- 1998-08-26 AU AU88904/98A patent/AU8890498A/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| See references of WO9910533A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU8890498A (en) | 1999-03-16 |
| WO1999010533A1 (en) | 1999-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6723505B1 (en) | Method for identification of the indicators of contamination in liquid samples | |
| US5298392A (en) | Process for detection of water-borne microbial pathogens and indicators of human fecal contamination in water samples and kits therefor | |
| Stender et al. | PNA for rapid microbiology | |
| JP2820675B2 (ja) | 遺伝上明確な群に対する特異的なヌクレオチド配列するヌクレオチド配列のスクリーニング方法 | |
| EP0235726A2 (de) | Schnellverfahren zum Nachweis von Nukleinsäure-Sequenzen in einer Probe mittels Probemarkierung | |
| JP3436538B2 (ja) | 改良型の鎖置換アッセイおよびそれに有用な複合体 | |
| US20160257997A1 (en) | Methods for whole-cell analysis of gram-positive bacteria | |
| US5554503A (en) | Sample processing method for Mycobacterium tuberculosis | |
| Lew et al. | Detection of Pseudomonas pseudomallei by PCR and hybridization | |
| Amann et al. | Identification and in situ detection of individual bacterial cells | |
| JPH07177900A (ja) | 水性懸濁液中でのインサイチューハイブリダイゼーションによる迅速微生物診断方法 | |
| AU773559B2 (en) | Method for detecting microorganisms in a sample | |
| US5426025A (en) | Species-specific DNA probes for vibrio vulnificus methods and kits | |
| Sohier et al. | Rapid and sensitive in situ hybridization method for detecting and identifying lactic acid bacteria in wine | |
| JP2000504922A (ja) | 混合集団における微生物の相対的存在量を定量するための方法および物質 | |
| US20210371940A1 (en) | Process for identifying and quantifying nucleic acid sequences from live microorganisms | |
| US6268143B1 (en) | Automated high throughput E. coli o157:H7 PCR detection system and uses thereof | |
| WO1999010533A1 (en) | Rapid detection and identification of micro-organisms | |
| AU2005217124A1 (en) | Method for detecting a microorganism in a fecal specimen | |
| US20090136930A1 (en) | Method for the identification of microorganisms by means of in situ hybridization and flow cytometry | |
| AU2003226729A1 (en) | Method for the identification of microorganisms by means of in situ hybridization and flow cytometry | |
| JP2002516679A (ja) | 有利に調節された特定成分の呈示量を含むカタログ化核酸ライブラリーの構築および使用 | |
| DK178306B1 (en) | Determination of Intracellular Bacteria | |
| ES2227222T3 (es) | Procedimiento para la identificacion, cuantificacion y visualizacion de microorganismos. | |
| EP0562765A2 (de) | Schnelltest zum Nachweis von Nukleinsäure-Bindungsfaktoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20000327 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20030301 |